Invesaro

Stocks Technology HNGE

NYSE · Technology

Hinge Health, Inc. (HNGE)

Hinge Health, Inc. brought in $800.8M of revenue over the twelve months to September 30, 2026. Net income was $168.3M, a net margin of 21.0%. Operating cash flow minus capital spending left $170.7M of free cash flow in fiscal 2025. At September 30, 2026 it held $211.6M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on November 9, 2026.

Free, no password. An email when HNGE files with the SEC.

Price
$123.23
+0.85% on the day · November 10, 2026
52-week range $30.08 to $124.94
Market cap
$9.9B
Revenue (last 12 months)
$800.8M
Net margin
21.0%

Key facts about Hinge Health, Inc.

Net worth
Hinge Health, Inc. has a market value (market cap) of $9.9B at the latest share price, and shareholders' equity of $299.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Revenue and profit
In fiscal 2025 revenue was $587.9M (+50.6% year on year), with a net loss of $528.3M. Over the 12 months to September 30, 2026: revenue $800.8M, net income $168.3M.
Cash flow
In fiscal 2025 operations brought in $171.4M of cash; after $708K of capital spending, free cash flow was $170.7M.
Latest report
The latest periodic report (quarterly report, 10-Q) was filed with the SEC on November 9, 2026 and covers the period to September 30, 2026. Open on SEC EDGAR
Next earnings report
Hinge Health, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

What Hinge Health, Inc. does

Hinge Health, Inc. is registered with the SEC under industry code SIC 7374 (Services-Computer Processing & Data Preparation). Its shares trade on NYSE under the ticker HNGE.

Revenue and profit by year

Revenue
FY23: $292.7M $292.7M FY23FY25: $390.4M $390.4M FY25FY25: $587.9M $587.9M FY25
Net income
FY23: -$108.1M -$108.1M FY23FY25: -$11.9M -$11.9M FY25FY25: -$528.3M -$528.3M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$587.9M-$546.4M-$528.3M-$7.77$170.7M
2025$390.4M-$31.9M-$11.9M-$0.88$48M
2023$292.7M-$130.5M-$108.1M-$8.31-$65.9M

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Next report expected around February 9, 2027.

Estimated from its filing rhythm: 52 weeks after its report of February 10, 2026. Not a date the company has announced. See the report calendar · Earnings, quarter by quarter

Where HNGE ranks in Technology

Revenue$587.9M
#304 of 751 in Technology · Top 40%
Revenue growth+50.6%
#59 of 604 in Technology · Top 10%
Net margin-89.9%
#571 of 611 in Technology · Bottom 7%
Free cash flow margin29.0%
#68 of 568 in Technology · Top 12%

Latest fiscal year of every company in the sector with the figure reported. Revenue is ranked among companies reporting in US dollars; growth and margins among companies with at least 10 million of revenue. Technology

Latest SEC filings

What Hinge Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. November 9, 2026
    Quarterly report 10-Q · period to September 30, 2026Revenue rose 52% to $235M versus the same quarter last year; diluted EPS $0.66 versus -$0.02.
  2. November 2, 2026
  3. August 21, 2026
  4. August 14, 2026
  5. August 14, 2026
  6. August 13, 2026
  7. August 6, 2026
    Quarterly report 10-Q · period to June 30, 2026Revenue rose 53% to $212.8M versus the same quarter last year; diluted EPS $0.52 versus -$13.10.
  8. August 4, 2026
  9. July 28, 2026
  10. June 9, 2026

Recent insider filings (Forms 3, 4 and 144): 10, the latest on November 6, 2026. Insider transactions on SEC

What is HNGE worth? A DCF from its reported cash flow

Insider trades

What the people running Hinge Health, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

Insiders sold $95.6M worth of shares in the last 90 days and bought none on the open market. All of the selling was pre-planned under Rule 10b5-1 trading plans.

Bought (open market)
$0
last 90 days
Sold
$95.6M
last 90 days
Net sold
1,024,581
$95.6M
DateInsiderWhatSharesPriceValueFiling
November 5, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 5, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 5, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 4, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 4, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 4, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 4, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4
November 4, 2026 Robinson ElliottDirector Soldindirect 0 - - Form 4

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns HNGE

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

HolderOf classSharesFiled
Daniel Antonio Perez13G, passive 15.7% 10,373,350 February 13, 2026
Gabriel M.I. Mecklenburg13G, passive 13% 4,025,963 August 13, 2025
Insight Venture Associates X, L.P.13G, passive with 6 related filers 9.4% 6,441,830 August 14, 2026

Latest filings below 5%: Deer X & Co. L.P. 3% (August 14, 2026); Qian Zhuang 4% (August 13, 2026); Atomico Advisors IV, Ltd. 2.88% (June 8, 2026); HANSAINVEST Hanseatische Investment-Limited Co 2.7% (April 27, 2026); The Vanguard Group 0% (March 27, 2026).

Largest institutional holders

Positions that investment managers reported on Form 13F for the quarter ended June 30, 2026, largest first, with the change on the quarter ended March 31, 2026. Managers file 13F up to 45 days after a quarter ends. 277 managers reported a position.

HolderSharesValueChange on quarter
BlackRock, Inc.3,570,131$296.3M+2,662,626
11.2 Capital Management, LLC2,464,657$204.6M-1,239,867
Vanguard Portfolio Management LLC2,146,032$178.1M+735,345
Deer Management Co. LLC1,908,707$158.4M-725,000
Vanguard Capital Management LLC1,892,834$157.1M+654,261
Two Sigma Investments, LP1,807,895$150.1M+1,424,016
Fuller & Thaler Asset Management, Inc.1,712,507$142.1M+57,309
Morgan Stanley1,613,901$134M+624,312
Franklin Resources Inc1,579,056$131.1M+620,523
Jane Street Group, LLC1,418,317$117.7M+861,186
Braidwell LP1,330,127$110.4M-124,996
Divisadero Street Capital Management, LP1,290,623$107.1M+719,964
Walleye Capital LLC1,267,650$105.2M+1,160,801
Wellington Management Group Llp1,205,584$100.1M+758,594
BIT Capital GmbH1,155,203$95.9M-1,154,594
Arrowstreet Capital, Limited Partnership1,118,968$92.9M-44,219
Bamco Inc1,117,678$92.8M-12,375
Marshall Wace, Llp1,052,232$87.3M+761,807
Goldman Sachs Group Inc1,011,256$83.9M+722,231
State Street Corp960,648$79.7M+825,248

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

7 insiders reported holding 4,421,947 shares in total, about $544.9M at the last price.

HolderSharesAs of
Bessemer Venture Partners X L.P.10% owner 3,383,7073,383,707 held indirectly November 18, 2025
Pursley JamesPresident 665,247 November 1, 2026
Budge JamesChief Financial Officer 292,114 November 1, 2026
Perez Daniel AntonioCEO & Co-Founder, Director, 10% owner 35,47035,470 held indirectly October 6, 2026
Leslie Kristina MDirector 30,387 August 20, 2026
Sloat TylerDirector 10,385 October 5, 2026
Wardi Teddie BenjaminDirector 4,6374,637 held indirectly August 10, 2026

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about HNGE

What does Hinge Health, Inc. do?

Hinge Health, Inc. is a company in the Technology sector, listed on NYSE as HNGE. Its shares trade on NYSE under the ticker HNGE.

What is Hinge Health, Inc.'s net worth?

Hinge Health, Inc. has a market value (market cap) of $9.9B at the latest share price, and shareholders' equity of $299.4M on its balance sheet at September 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Hinge Health, Inc. profitable?

Yes. Over the twelve months to September 30, 2026 it reported net income of $168.3M on revenue of $800.8M, a net margin of 21.0%.

How much revenue does Hinge Health, Inc. make?

Over the twelve months to September 30, 2026 Hinge Health, Inc. reported revenue of $800.8M.

When did Hinge Health, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on November 9, 2026. It covers the period to September 30, 2026.

When is Hinge Health, Inc.'s next earnings report?

Hinge Health, Inc.'s next report is expected around February 9, 2027. That is an estimate from its filing rhythm, not a date the company has announced.

Similar companies

Compare HNGE with

Compare HNGE with any company

Follow HNGE

Get an email when Hinge Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Free, no password. An email when HNGE files with the SEC.

Where the numbers come from

Financial figures are the values Hinge Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.